Effect and its mechanism of Juglone on invasion and metastasis ability of human cervical cell line HeLa

ZHAO Xing-yu HOU Jian-cheng JIN Lian-hai WANG Yu-qi LIU Song ZHANG Wei*

doi:10.16098/j.issn.0529-1356.2017.02.007

PDF(565 KB)

Acta Anatomica Sinica ›› 2017, Vol. 48 ›› Issue (2) : 160-164. DOI: 10.16098/j.issn.0529-1356.2017.02.007

Cancer Biology

Effect and its mechanism of Juglone on invasion and metastasis ability of human cervical cell line HeLa

ZHAO Xing-yu HOU Jian-cheng JIN Lian-hai WANG Yu-qi LIU Song ZHANG Wei*

Author information +

History +

Abstract

Objective To observe the effect of Juglone on invasion and metastasis of Hela cells and explore the possible mechanism. Methods HeLa cells were cultured and treated with 10,20,50,100μmol/L Juglone for 24 hours. The morphology changes of HeLa cells were observed with an inverted microscope. The viability of HeLa cells was detected by MTT assay. The cell scratch test was used to detect cell migration ability after treatment of Juglone. The ability of cell invasion was measured by Transwell chamber. The expression of matrix metalloprateinases (MMP)-2 and MMP-9 were detected by Western blotting. Results Compared with control group, the viability of HeLa cells decreased after treatment with different concentrations of Juglone for 24 hours, and the cell morphology was changed in a dose-dependent manner. Scratch test results showed that the level of cell movement ability decreased significantly with the increase of the concentration of Juglone. Transwell invasion assay showed that Juglone had a strong inhibitory effect on the invasiveness of HeLa cells in vitro. Western blotting results showed that Juglone inhibited the expression of MMP-2 and MMP-9 protein in HeLa cells. Conclusion Juglone can inhibit the invasion and metastasis in HeLa cells, and its possible mechanism may be related to down regulating the expression of MMP-2 and MMP-9.

Key words

Juglone / HeLa cell / Invasion / Metastasis / Western blotting / Human

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHAO Xing-yu HOU Jian-cheng JIN Lian-hai WANG Yu-qi LIU Song ZHANG Wei. Effect and its mechanism of Juglone on invasion and metastasis ability of human cervical cell line HeLa[J]. Acta Anatomica Sinica. 2017, 48(2): 160-164 https://doi.org/10.16098/j.issn.0529-1356.2017.02.007

References

［1］Gonzaleal MA,Tin A. Molecular biology of cervical cancer［J］. Clin Transl Oncol，2007，9(6):347-354.

［2］Gao Ye, Zhang J, Wu J, et al. Detection and genotyping of human papillom aviru sDNA in cervical cancer tissues with fluorescence polarization［J］. Acta Biochim Biophys Sin，2003，35(11 ): 1029-1034.

［3］Sugie S, Okamoto K, Rahman KM, et al. Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats［J］. Cancer Lett, 1998,127(1):177-183.

［4］Chao SH, Greenleaf AL, Price DH. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription［J］. Nucleic Acids Res, 2001,29(3):767-773.

［5］Varga Z, Bene L, Pieri C, et al. The effect of Juglone on the membrane potential and whole-cell K+ currents of human lymphocytes［J］. Biochemical and Biophysical Research Communications, 1996, 218(3):828-832.

［6］Xu HL, Yu XF, Qu SC, et al. Anti-proliferative effect of Juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-dependent pathway［J］. Eur J Pharmacol, 2010, 645(1-3):14-22.

［7］Xie J, Bai J, Sheng X, et al. Proliferation inhibition of human cervical cancer HeLa cells by Casticin in vitro［J］. The ChineseGerman Journal of Clinical Oncology，2011，10(1): 47-50.

［8］Malaguti C, Ciminiello P, Fattorusso E, et al. Caspase activation and death induced by yessotoxin in HeLa cells ［J］. Toxicol In Vitro, 2002, 16(4):357-363.

［9］Zhang W, Liu A, Li Y, et al. Anticancer activity and mechanism of juglone on human cervical carcinoma HeLa cells［J］. Can J Physiol Pharmacol, 2012,90(11):1553-1558.

［10］Lordick F， Hlscher AH， Haustermans K, et al. Multimodal treatment of esophageal cancer［J］. Langenbecks Arch Surg，2013，398(2):177-187.

［11］Ray ME，Mehra R，Sandler HM，et al. E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes［J］. J Urol，2006，176(4 Pt1):1409-1414.

［12］Li W，Saji S，Sato F，et al. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects［J］. Int J Biol Markers，2013，28(2):e117-130.

［13］Jang ChZh,Chen JF,He LSh,et al. The fuction of MMP-2 and MMP-9 in primary Human brain gliomas invasion［J］. Acta Anatomica Sinica, 2001,32(4):346-349. (in Chinese)

江常震, 陈锦峰, 何理盛, 等. MMP-2和MMP-9在人脑原发性胶质瘤侵袭中的作用［J］.解剖学报,2001,32(4):346-349.

［14］Wang XJ,Yang YJ,Tian HN,et al. Effects of annexin A5 low expression on migration and invasion of HeLa cells［J］. Acta Anatomica Sinica, 2016，47(4):487-492. . (in Chinese)王小杰, 杨艳杰,田焕娜,等.膜联蛋白 A5 低表达对人宫颈癌 HeLa 细胞迁移和侵袭的影响［J］. 解剖学报，2016，47(4):487-492.

［15］Radenkovic S，Konjevic G，Jurisic V，et al. Values of MMP-2 and MMP-9 in tumor tissue of basal-like breast cancer patients［J］. Cell Biochem Biophys，2014，68(1): 143-152.

［16］Shao W，Wang W，Xiong XG，et al. Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer［J］. J Surg Oncol，2011，104(7): 841-846.